Soundbite Medical Solutions Announces FDA Approval for SoundBite® Crossing System – Peripheral (14P)
Soundbite announces FDA 510(k) Approval for SoundBite® Crossing System - Peripheral (SCS-P) with the 0.014” Active Wire (14P). Read More →
Soundbite Medical Wins Health Canada Approval for PAD Treatment
The SCS-P (14P) is intended to treat patients suffering from PAD with heavily calcified above-the-knee (ATK) and below-the-knee (BTK) chronic total occlusions (CTO). Read More →
SoundBite Receives FDA 510(k) Clearance of the SoundBite Crossing System – Peripheral
MONTREAL January 21, 2020 – SoundBite Medical Solutions Inc. (SBMS) today announces it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the SoundBite™ Crossing System, a unique active wire technology for use in the treatment of peripheral chronic total... Read More →